TL;DR: In this article, the authors explain why innovating firms often fail to obtain significant economic returns from an innovation, while customers, imitators and other industry participants be- nefit.
TL;DR: A patent confers, in theory, perfect appropriability (monopoly of the invention) for a limited time in return for a public benefit as mentioned in this paper, however, the benefits consumers derive from an innovation, however, are increased if competitors can imitate and improve on the innovation to ensure its availability on favorable terms.
Abstract: To HAVE the incentive to undertake research and development, a firm must be able to appropriate returns sufficient to make the investment worthwhile. The benefits consumers derive from an innovation, however, are increased if competitors can imitate and improve on the innovation to ensure its availability on favorable terms. Patent law seeks to resolve this tension between incentives for innovation and widespread diffusion of benefits. A patent confers, in theory, perfect appropriability (monopoly of the invention) for a limited time in return for a public
TL;DR: Privatization of biomedical research must be more carefully deployed to sustain both upstream research and downstream product development, because more intellectual property rights may lead paradoxically to fewer useful products for improving human health.
Abstract: The “tragedy of the commons” metaphor helps explain why people overuse shared resources. However, the recent proliferation of intellectual property rights in biomedical research suggests a different tragedy, an “anticommons” in which people underuse scarce resources because too many owners can block each other. Privatization of biomedical research must be more carefully deployed to sustain both upstream research and downstream product development. Otherwise, more intellectual property rights may lead paradoxically to fewer useful products for improving human health.
TL;DR: In this paper, the authors examine the patenting behavior of firms in an industry characterized by rapid technological change and cumulative innovation and find that semiconductor firms do not rely heavily on patents to appropriate returns to R&D.
Abstract: We examine the patenting behavior of firms in an industry characterized by rapid technological change and cumulative innovation. Recent survey evidence suggests that semiconductor firms do not rely heavily on patents to appropriate returns to R&D. Yet the propensity of semiconductor firms to patent has risen dramatically since the mid1980s. We explore this apparent paradox by conducting interviews with industry representatives and analyzing the patenting behavior of 95 U.S. semiconductor firms during 1979‐1995. The results suggest that the 1980s strengthening of U.S. patent rights spawned ‘‘patent portfolio races’’ among capital-intensive firms, but it also facilitated entry by specialized design firms.
TL;DR: In this paper, the authors investigate the use of patent protection and cooperative agreements among firms to protect incentives for cumulative research in high-technology development, where almost all technical progress builds on a foundation provided by earlier innovators.
Abstract: Most innovators stand on the shoulders of giants, and never more so than in the current evolution of high technologies, where almost all technical progress builds on a foundation provided by earlier innovators. Most economics literature on patenting and patent races has looked at innovations in isolation, without focusing on the externalities or spillovers that early innovators confer on later innovators. But the cumulative nature of research poses problems for the optimal design of patent law that are not addressed by that perspective. The challenge is to reward early innovators fully for the technological foundation they provide to later innovators, but to reward later innovators adequately for their improvements and new products as well. This paper investigates the use of patent protection and cooperative agreements among firms to protect incentives for cumulative research.